Company Overview Visit bd.com website
Becton Dickinson & Company is an international medical technology company that manufactures and sells medical devices, instrument systems, reagents, and instruments used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, among others. The company was founded in 1897 as a maker of rubber products. BD currently employs about 35 thousand people worldwide.
As of 2014 the net income totaled to US$ 1.076 billion with US$ 518 million for research and development.
The company operates in three segments: BD Medical (51% of 2014 revenue), BD Life Sciences (27%),and BD Biosciences (22%).
Becton Dickinson was ranked No. 6 on Fortune 500 list of U.S.-based manufacturing companies for 2013.
BD's history began in 1897 when Maxwell W. Becton and Fairleigh S. Dickinson, two New Jersey inventors, founded the "Becton-Dickinson Microliter Company" with $10,000 each as initial capital stock after their previous rubber company failed during a recession. The company manufactured small glass feeding bottles and flasks for home use by pharmacists at a time when precise measurement was needed to administer proper medicine doses. In 1898 it introduced its first syringe designed for intra-muscular injection and throughout much of the 20th century was a leader in research on intravenous solutions. In 1932 it began marketing its first blood collection tubes made from thick glass which reduced breakage from the now well known thin walled tubes made from more fragile glass. It also helped to develop the first plastic syringe in 1950, and introduced the Glass Syringe thick-walled blood collection tube in 1958.